Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Chinese Drug Shows Benefit in HER2-Low Breast Cancer

(MedPage Today) -- An investigational antibody-drug conjugate (ADC) significantly reduced the risk of disease progression or death in patients with HER2-low metastatic breast cancer, a Chinese phase III trial showed. The drug, trastuzumab rezetecan...

Chinese Drug Shows Benefit in HER2-Low Breast Cancer

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

Ebola: Kenya announces second death

Kenyan health officials said the 65-year-old woman was a close relative of a man who died of Ebola last month. The woman developed symptoms while under quarantine in Nairobi.

Ebola: Kenya announces second death

Kenyan health officials said the 65-year-old woman was a close relative of a man who died of Ebola last month. The woman developed symptoms while under quarantine in Nairobi.

Ebola: Kenya announces second death

Kenya has recorded a second Ebola death, the Health Ministry said late Friday. The 65-year-old woman had developed symptoms during quarantine and was a close relative of a Kenyan man who died of the…

More from Friday 23 October →